Clinical Trial Results:
A double-blind, 3-arm study on weight loss with combination of micronised fenofibrate 267 mg and metformin 1700 mg per day compared to metformin 1700 mg and placebo, at 6 months, in obese patients,
Followed by
A double-blind, 2-arm investigation of weight-loss maintance with same combination of micronised fenofibrate 267 mg and metformin 1700 mg compared to placebo, at 6 months, in the resporders.
Summary
|
|
EudraCT number |
2004-001731-28 |
Trial protocol |
FI |
Global completion date |
10 Feb 2006
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
18 Dec 2019
|
First version publication date |
18 Dec 2019
|
Other versions |
|
Summary report(s) |
C LF 23-0121 04 01 - Version 2.0 - Synopsis_Redacted |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.